Canopy Growth (CGC) Interest Coverage Ratio Growth (1y) (2020 - 2026)
Canopy Growth (CGC) Interest Coverage Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Canopy Growth | 443.38 Mn | 196.37 Mn | 16.08 Mn | 24.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.92% |
| Dec 31, 2025 | -79.13% |
| Sep 30, 2025 | 11.11% |
| Jun 30, 2025 | -68.74% |
| Dec 31, 2024 | 42.00% |
| Sep 30, 2024 | -744.78% |
| Jun 30, 2024 | 18.92% |
| Mar 31, 2024 | 68.05% |
| Dec 31, 2023 | 27.65% |
| Sep 30, 2023 | 94.78% |
| Jun 30, 2023 | 97.52% |
| Mar 31, 2023 | -18.28% |
| Dec 31, 2022 | 40.38% |
| Sep 30, 2022 | 39.43% |
| Jun 30, 2022 | -796.25% |
| Mar 31, 2022 | 38.77% |
| Dec 31, 2021 | 98.94% |
| Sep 30, 2021 | 95.67% |
| Jun 30, 2021 | 94.88% |
| Mar 31, 2021 | 96.12% |